loading

Olema Pharmaceuticals Inc Stock (OLMA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
12.90%
34.34
30.42 23.34 21.60 29.60
Operating Income/Loss
12.90%
-34.34
-30.42 -23.34 -21.60 -29.60
Nonoperating Income/Loss
7.55%
3.369
3.644 1.84 1.506 1.316
Income/Loss From Continuing Operations Before Tax
15.69%
-30.97
-26.77 -21.50 -20.09 -28.29
Income/Loss From Continuing Operations After Tax
15.68%
-30.97
-26.77 -21.50 -20.09 -28.29
Net Income/Loss
15.68%
-30.97
-26.77 -21.50 -20.09 -28.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,611%
55.57
3.2471 44.98 40.72 40.35
Diluted Average Shares
1,611%
55.57
3.2471 44.98 40.72 40.35
Basic Earnings Per Share
16.67%
-0.56
-0.48 -0.48 -0.49 -0.70
Diluted Earnings Per Share
16.67%
-0.56
-0.48 -0.48 -0.49 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):